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NK cells are innate lymphocytes that play a key role in the control of various viral
infections. Recent studies indicate that NK cells may acquire some features of adaptive
immune cells, including the formation of long-lived memory cells. A large and growing
body of data indicates that NK cells regulate the adaptive immune response as well. The
function and the activation status of NK cells are tightly regulated by signals induced by
a broad range of inhibitory and activating cell surface receptors and cytokines released
by other immune cells. Here, we review the function of mouse NK-cell receptors involved
in virus control and in the regulation of the adaptive immune response. In addition, we
discuss viral strategies used to evade NK-cell-mediated control during infection. Finally,
the role of several activating Ly49 receptors specific for mouse cytomegalovirus (MCMV),
as well as some controversial issues in the field, will be discussed.
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NK cells in viral infections
NK cells are innate cytotoxic lymphocytes essential for the
control of a broad range of viral infections. The activation and
function of NK cells are based on a tightly regulated interplay
between inhibitory and activating signals induced by the recep-
tors expressed on their surface (reviewed in [1]) or by a variety
of cytokines generated by the interaction between NK cells and
other innate immune cells, such as macrophages and DCs [2, 3].
Type I IFNs, IL-12, IL-15, and IL-18 produced by macrophages
and DCs are indispensable for NK-cell maturation and regulation
of NK-cell function. More recently, it has been demonstrated that
TGF-β signaling limits the maturation dynamics of NK cells during
the neonatal period [4]. Mice lacking the TGF-β receptor on the
surface of their NK cells and DCs possess more mature NK cells
and can therefore control viral infectionmore efficiently compared
with control mice [4], providing an explanation for the deficient
NK-cell response early in life.
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The impact of NK cells on virus control has been proven to
play a key role in different infection models including those mod-
eling infection with influenza virus, HIV, HCV, coxsackievirus,
and poxviruses. Arguably, the role of NK cells in the control of
herpesviruses, especially CMV, has been most widely studied up
till now (reviewed in [5–7]). Upon activation and recruitment
to the site of infection, NK cells use several mechanisms to limit
virus replication: (i) a cytolytic response involving the secretion of
cytolytic granules (granzymes and perforin) upon engagement of
an activating receptor [8, 9], (ii) production of pro-inflammatory
cytokines with antiviral activity such as IFN-γ and TNF-α [10],
(iii) killing of target cells via FasL or TRAIL [11], and (iv) Ab-
dependent, cell-mediated cytotoxicity-mediated lysis via CD16
[12].
Besides their well-recognized role in the control of virus repli-
cation, NK cells have been shown to possess additional functions
that can be beneficial or detrimental to the host. For instance,
decidual NK cells are considered to be important for placenta-
tion and maintenance of materno-fetal immune tolerance [13],
but there is a very limited amount of data published on the
role of NK cells in the control of infections during pregnancy. In
mouse cytomegalovirus (MCMV)-infected mice, NK cells preserve
the integrity and function of the salivary gland, an organ that is
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
868 Antonija Miletic´ et al. Eur. J. Immunol. 2013. 43: 867–877
important for horizontal virus spread [14, 15]. A study using the
mouse model of salivary gland dysfunction after an acute MCMV
infection showed the involvement of NK cells in the prevention of
acinar atrophy and loss of secretions [16]. Conversely, the NK-cell
response could play a negative role in virus infection, as demon-
strated in the case of infection with RSV [17]. NK cells accumulate
in the lungs of BALB/c mice at the early stage of RSV infection,
where they gain an activated phenotype accompanied by high pro-
duction of IFN-γ, and are responsible for the resulting acute lung
injury [17], demonstrating a thin line between protective function
and immunopathology. Likewise, although the role of NK cells in
the control of influenza virus infection is well established [18], a
recent study demonstrated that these cells can also contribute to
the pathology by increasing pulmonary inflammation [19].
Studies in mice using the lymphocytic choriomeningitis virus
(LCMV) showed that despite the induction of type I IFNs and the
stimulation of NK-cell cytotoxic functions, NK cells do not play a
role in the early clearance of this virus [20]. A recent study in
LCMV-infected mice revealed a role for NK cells in the regula-
tion of adaptive immunity [21]. A considerable number of studies
using MCMV as an infection model confirm NK-cell involvement
in shaping the adaptive immune response [22–27].
The main issues addressed in this review include the role of
NK cells and their receptors in the control of virus infection and
the strategies that viruses have evolved to evade and modulate
immune response.
Mouse NK-cell receptors in response to viral
infections
NK cells are regulated by a careful balance of signals from their
inhibitory and activating receptors. Viruses, on the other hand, try
to prevent the engagement of activating receptors or preserve a
default inhibitory state at any cost (Fig. 1). The two most frequent
approaches used by viruses to preserve the inhibitory state include
direct targeting of NK-cell receptors and interfering with NK-cell
receptor ligands. Unlike B and T cells, which use RAG enzymes for
rearranging their receptor genes and consequently gain numerous
combinations of Ag-specific receptors [28,29], NK cells widen the
diversity of Ag recognition by differential expression of a large set
of germline-encoded inhibitory and activating NK-cell receptors
on their cell surface.
NK-cell receptors are classified into two main families accord-
ing to their extracellular domain: (i) the C-type lectin like family
and (ii) the Ig-like receptor family [30]. In mice, many of the
genes encoding members of the C-type lectin-like NK-cell recep-
tors, as well as the genes that encode some of their ligands, are a
part of the Natural Killer gene Complex (NKC) located on mouse
chromosome 6 (reviewed in [31]). These include the killer lectin-
like family a (Klra, or Ly49 receptors), representing the func-
tional mouse homologues of killer Ig-like receptors (KIRs) found
in humans. The Ly49 family comprises both inhibitory and acti-
vating members, many of them specific for MCMV (reviewed in
[32,33]).Members of Klrc (or NKG2 receptors) and Klrd (or CD94)
are expressed as heterodimers on overlapping NK-cell subsets, in
which the NKG2A/CD94 complex encodes inhibitory receptors,
while NKG2C/CD94 and NKG2E/CD94 exhibit activating proper-
ties [34]. Recent findings indicate that NKG2E/CD94 is essential
for the resistance of C57BL/6 mice to mousepox, which is caused
by the orthopoxvirus ectromelia virus (ECTV). ECTV-infected cells
expressing the MHC-class-Ib molecule (Qa-1(b)) are specifically
recognized by this activating receptor [35]. Klrb (or NKRP1) and
its ligand Clr-b expressed within NKC were shown to be important
in the control of poxvirus infection [36,37]. Furthermore, Klrk (or
NKG2D), one of the most important activating NK-cell receptors
involved in the control of various infections and tumor transfor-
mation recognition (reviewed in [38]), also belongs in this large
C-type lectin-like family, as do CD69 and Klrg1 (or MAFA1). Con-
versely, mouse Ig-like NK-cell receptors include members such as
the paired-Ig receptor family (Pir, or ILT), the Natural cytotoxicity
receptor 1 gene (Ncr1, or Nkp46) and the 2B4 receptor. The NCR1
receptor is the only member of the NCR receptor family expressed
in mice. This activating receptor was found to be important in
the control of several bacterial and viral infections including the
influenza virus (reviewed in [39]). Furthermore, the CD96 recep-
tor belonging to the same Ig-like family, shares a ligand with
an activating (DNAM1) and an inhibitory (T-cell immunoreceptor
with Ig and ITIM domains (TIGIT)) receptor expressed on NK cells.
All three receptors competitively recognize the poliovirus receptor
(PVR, or CD155), which is expressed on many cell types of epithe-
lial origin as well as on monocytes and DCs (reviewed in [40]).
Finally, it is important to emphasize that the expression of
some NK-cell receptors (e.g. Ly49s) is stochastic, so each NK cell
is unique with regards to the repertoire of receptors it expresses,
which can ultimately have a great influence on the immunological
response and the resolution of the viral infection.
Viral evasion of NK cells by modulation
of MHC class I molecules
Most of the known ligands for inhibitory NK-cell receptors are
MHC class I (MHC-I)molecules with differential binding specificity
and affinity for specific inhibitory receptors [41]. Since MHC-I
molecules are expressed on practically all nucleated cells, it is not
surprising that, in order to avoid the targeting of healthy cells, the
default state of NK cells is inhibition. However, the downregula-
tion of MHC-I expression from the surface of infected cells, which
is a consequence of viral evasion mechanisms aimed at avoiding
detection and lysis by CD8+ T cells, should induce the activa-
tion of NK cells in a process termed “the missing self” recognition
[42]. By this mechanism, the ligand-deprived inhibitory NK-cell
receptors can no longer suppress NK-cell activity, thus leading to
a prevalence of positive signaling coming from activating NK-cell
receptors.
Inhibitory Ly49 receptors, which recognize MHC-I molecules
as their cellular ligands, comprise the majority of inhibitory recep-
tors found on mouse NK cells. MCMV encodes three proteins
that modulate the expression of MHC-I molecules on infected
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Figure 1. Modulation of ligand–receptor interactions as a result of viral immunoevasion. NK-cell activation is tightly regulated by the interplay
between inhibitory and activating signals coming from receptors expressed on the cell surface of NK cells. In order to disrupt NK-cell activation,
viruses employ a plethora of different immune evasion tactics. The schematic representation includes activating and inhibitory mouse NK-cell
receptor-ligand pairs and the corresponding immune evasion mechanisms that viruses use in order to disrupt their interaction. MCMV evades
NK cells by employing several immune subversive approaches including the downregulation of ligands for the activating (NKG2D, NCR1, DNAM-1)
NK-cell receptors. The engagement of inhibitory receptors by viral ligand alone (m157) or in a complex with MHC-class-I molecules (m04/MHC-I)
results in the avoidance of NK-cell activation by the missing self recognition. In some mouse strains the same viral proteins (m157, m04 in a
complex with MHC-I) are recognized, in addition, by activating receptors resulting in NK-cell activation. Influenza virus HA expressed on infected
cells is recognized by NCR1. To avoid this, influenza virus releases free HA which enters the NK cells and induces CD3-ζ degradation, thus
limiting the signaling through NCR1. Zoonotic orthopox viruses (ZPXV) directly prevent NKG2D signaling by encoding competitive soluble ligands.
Orthopoxvirus ectromelia virus (ECTV) upregulates the expression of the Qa-1 molecule on infected cells that leads to an increased proportion
of NK cells expressing the activating CD94/NKG2E receptor at the expense of those expressing the inhibitory CD94/NKG2A receptor. NKRP-1 is
important in the control of ECTV and vaccinia virus (VV) infection, since those viruses induce the downregulation of Clr-b, a ligand for this
inhibitory receptor, which results in NK-cell activation. On the other hand, rat CMV (RCMV) encodes for the Clr-b homolog (RCTL) which, in
addition to Clr-b downregulation, results in immune evasion.
cells [43]. The m152/gp40 [44] and m06/gp48 [45] proteins
downregulate MHC-I molecules by retaining them at the level
of the ERGIC/cis Golgi compartment or by redirecting them to
lysosomes for degradation, respectively. However, the m04/gp34
protein does not downregulate MHC-I molecules but instead binds
to these molecules and escorts them to the cell surface [46]. By
doing so, the m04 protein not only antagonizes the function of
two other MCMV inhibitors, but also provides sufficient surface
MHC-I molecules to serve as a ligand for inhibitory Ly49 receptors
[46, 47]. It has been proposed that the main role of m04 is viral
avoidance of NK-cell killing by the missing self axis. The formal
evidence for this hypothesis came from our studies showing that
the deletion of m04 from the MCMV genome sensitizes the virus
to NK-cell control in vivo [48]. Cowpox virus also encodes for pro-
teins involved in the downregulation of mouse MHC-I molecules
[49, 50], but it is not clear how this virus avoids missing self-
dependent NK-cell activation.
Another viral mechanism used by MCMV to interfere with NK-
cell dependent virus control is the generation of MHC-I homo-
logues that serve as a decoys for inhibitory receptors. Most of
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these viral proteins attain an MHC-I-like fold, but since these
viral proteins do not present peptides they provide the virus with
another evasion mechanism to avoid the activation of NK cells.
MCMV encodes for several MHC-I-like molecules — m144, m145,
m152, m153, m155, and m157 proteins within its m145 fam-
ily [51]. The role of several of these molecules in immune eva-
sion has been extensively studied. Likewise, the m152 protein has
also been proved to be an important viral tool used in the down-
regulation of MHC-I molecules from the surface of the infected cell
[44]. In addition, m152 has also been shown to play a part in the
downregulation of NKG2D ligands along with two other members
of the same family, the m145 protein and the m155 protein [52].
The m157 viral protein can be recognized by both inhibitory
(Ly49I) and activating (Ly49H) NK-cell receptors, thus represent-
ing a very important factor in the regulation of host’s immune
response [53]. However, the exact function of some viral proteins,
such as m144 and m153, and the corresponding mechanisms used
in evading NK-cell-mediated viral control still remain to be eluci-
dated [54,55].
The engagement of inhibitory NK-cell receptors also plays a
significant role in the functional NK-cell maturation. NK cells
expressing inhibitory receptors that bind to self-MHC-I are con-
sidered “licensed” and are thus functionally more responsive to
stimulation [56]. On the other hand, the so-called “unlicensed”
cells lacking any known inhibitory receptor exhibit an impaired
response upon ligation of activating receptors in vitro [57].
However, a study by Orr et al. [58] indicates that “unlicensed”
NK cells are capable of mediating MCMV control in vivo, suggest-
ing that NK cells lacking inhibitory receptors may be important
for NK-cell control of certain infections. As an explanation the
authors suggest that, despite the fact that MCMV downregulates
the expression of surface MHC-I, residual amounts of MHC-I on
the surface of infected cells are still sufficient to engage inhibitory
receptors expressed by licensed NK cells and thus interfere with
NK-cell activation via Ly49H recognition of m157 [58].
MCMV-specific activating Ly49 receptors
In response to viral immune subversion strategies, evolutionary
pressure on the host has resulted in newly evolving activating NK-
cell receptors [59]. For example, the activating receptor Ly49H,
expressed on the surface of NK cells, confers resistance to MCMV
in C57BL/6 mice [60–62]. Ly49H-exclusive and -direct ligation
of m157 initiates strong NK-cell activation, involving a clonal
expansion of Ly49H+ NK cells and the secretion of proinflam-
matory cytokines, resulting in the killing of infected cells and
a rapid control of viral replication by day 3 p.i. [51, 53, 63].
The m04 protein is another example of an MCMV protein that
can influence the recognition by both inhibitory and activating
Ly49 receptors. Contrary to the m157/Ly49 interaction, both the
viral m04 protein and the host’s H-2Dk/d molecule are needed
for the recognition of m04 by Ly49P [64]. Interestingly, another
uncharacterized host or viral factor is required for successful
Ly49P/m04/H-2Dk-mediated recognition of MCMV-infected cells
since Ly49P reporter cells could not recognize H-2Dk-bearing
target cells that artificially expressed m04. The infection of H-2Dk-
bearing target cells expressing m04 with m04-deficient MCMV
restored Ly49P recognition. In addition to Ly49P, several other
activating Ly49 receptors can recognize MCMV-infected cells in
an m04/H-2-specific fashion [65]. However, in contrast to the
prompt activation and clonal expansion of Ly49H+ NK cells upon
Ly49H receptor engagement early after infection in C57BL/6mice,
Ly49 activating receptors recognizing them04/MHC-I complex are
hindered by inhibitory receptors competing for the same ligand.
Therefore, the activating capacity of Ly49 receptors only becomes
apparent at a later point in the infection. In addition, it has recently
been shown that triggering of the activating Ly49P receptor by the
m04/MHC-I H-2Dk complex can be abolished by the engagement
of the Ly49 inhibitory receptor if the target cells simultaneously
express MHC-I H-2q molecules, which strongly inhibits NK cells
[66].
According to these findings, numerous activating and
inhibitory Ly49 receptors share ligands for the recognition of
infected cells, which points to the possibility that activating recep-
tors originated from inhibitory ones as a host response to selective
pressure by the virus. This would most certainly explain why viral
proteins such as m157 and m04, which originally evolved as lig-
ands for inhibitory NK-cell receptors, can also be recognized by
their activating counterparts.
Viral modulation of NKG2D receptor
functions
NKG2D is a highly evolutionarily conserved receptor expressed
on all NK cells, the majority of NKT cells, subsets of γδ T cells, all
human CD8+ T cells, activatedmouse CD8+ T cells, and a subset of
CD4+ T cells. NKG2D is considered one of the most important NK-
cell receptors, responsible for triggering NK-cell cytolytic activity
as a response to cellular stress due to tumor transformation or
infection (reviewed in [67]). NKG2D recognizes a wide variety
of MHC-like cellular ligands, characterized by a great diversity in
structure and expression patterns but with one important feature
in common – low expression in healthy cells that gets induced upon
the first signs of cellular stress, ensuring that the immune system
receives the necessary alert signal [68]. For example, infection
with a neurotropic strain of mouse hepatitis virus (MHV) increased
the transcription of NKG2D ligands in the brain of infected mice,
thus enabling the signaling via this activating receptor. Signaling
via NKG2D was abolished by the administration of an anti-NKG2D
blocking Ab resulting in an increased mortality of MHV-infected
mice [69], further confirming the role of NKG2D in the control of
MHV.
The importance of NKG2D in immune surveillance is proba-
bly best illustrated by several viral approaches used to neutral-
ize the activity of this NK-cell receptor. One such successful viral
tactic for immune subversion is encoding for proteins that down-
regulate the expression of the ligands of this activating NK-cell
receptor. MCMV protein m145 affects the surface expression of
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MULT-1, m152 targets the RAE-1 family, whereas m155 tar-
gets H60 [52, 54, 70]. Furthermore, surface expression of H60,
MULT-1, and RAE-1ε is additionally downregulated bym138/fcr-1
(Fig. 1). The deletion of any of the above-mentioned viral genes
results in decreased viral titers in the organs of infected animals,
emphasizing their importance inMCMV immune evasion.We have
recently shown that the insertion of the NKG2D ligand RAE-1 in
place of its viral inhibitor m152 dramatically increases the suscep-
tibility of the virus to immune control in vivo, but does not affect
its capacity to induce a protective CD8+ T-cell response [71].
Zoonotic orthopox viruses employ a different approach to evad-
ing the NKG2D receptor. These viruses encode for a MHC-I-like
competitive antagonist of NKG2D, focusing their evasion directly
on the activating receptor rather than affecting the ligand expres-
sion [72].
Other MHC-I independent immune evasion
strategies of NK cells
NKp46/NCR1 is another important NK-cell activating receptor
implicated in the control of various viral and bacterial infections
[18,73–76]. Several groups have reported that undefined NKp46
ligand(s) are expressed on DCs and macrophages, thus emphasiz-
ing the importance of these receptor-ligand interactions in NK-cell
activation during viral infections [75,77].While the cellular ligand
for NKp46/NCR1 remains undefined, HA and HA-neuraminidase
from several viruses, including the influenza virus, are known to
ligate NKp46 (reviewed in [39]). It has been shown that human
NKp46 recognizes viral HA in a sialic acid-dependent manner
and that glycosylation is essential for NKp46 binding to viral HA.
Recently, these findings were confirmed for the mouse ortholog,
NCR1 as well [78]. In addition, free HA released with new virions
from infected cells can inhibit NK-cell cytotoxicity by entering the
cell and inducing CD3-ζ degradation, thus providing the virus with
the mechanism to avoid efficient receptor activation [79]. Namely,
as NCR1 employs the CD3-ζ adaptor molecule for signal trans-
duction, signaling from this receptor is thus efficiently blocked
(Fig. 1). The importance of NCR1 in the control of influenza virus
has also been confirmed in vivo [18]. NCR1gfp/gfp mice, in which
the gene encoding for NCR1 receptor is replaced with a green
fluorescent protein reporter cassette, show increased susceptibil-
ity to lethal influenza infection [18]. In contrast, our own study
addressing the role of NCR1 in MCMV infection revealed a lack of
difference in the early control of the virus between Ncr1gfp/gfp mice
and control mice (unpublished data). This was a surprising and
unexpected finding that led us to question whether this is a conse-
quence of viral evasion of NCR1, or whether signaling through this
receptor plays no role in the control of this virus. Bearing in mind
that we have previously shown that MCMV can completely block
NKG2D-dependent virus control by downregulating its cellular
ligands, we have decided to assess whether, similar to the situa-
tion for NKG2D ligands, MCMV downregulates the cellular ligands
for the NCR1 receptor. Indeed, binding of NCR1 fusion protein was
reduced in MCMV-infected mouse fibroblasts in comparison with
that of uninfected cells, indicating that MCMV downregulates the
cellular ligand for this receptor (unpublished data). This finding
might explain the similar levels of virus control seen when com-
paring WT (control) and Ncr1gfp/gfp mice.
Interestingly, Noe´ mice, which have a mutation in Ncr1, show
a different phenotype as compared to Ncr1gfp/gfp mice, with Noe´
mice displaying hyperactivation of NK cells [80]. The reason for
this hyperactivated phenotype is unknown, but it results in better
control of viruses such as MCMV and influenza virus, thus indicat-
ing an as-yet unrevealed regulatory role for this activating recep-
tor in NK-cell viral control. These contradictory findings might
be explained by differences between Ncr1gfp/gfp and Noe´ mice:
although both mouse strains lack surface expression of NCR1, at
the DNA level the Ncr1gfp/gfp mice retain only a portion of the
Ncr1 extracellular domain, while Noe´ mice possess a single point
mutation (W32R) in an otherwise completely preserved Ncr1 gene
[18, 80]. Further investigations are needed to reveal the discrep-
ancies concerning the role of this activating NK-cell receptor.
PVR/CD155 receptor, expressed on the surface of different
hematopoetic cells including monocytes and DCs, was found to be
a ligand for TIGIT [81–83], CD96, and DNAM1 receptors [84,85],
which further supports the necessity of a fine balance between
inhibitory and activating signals in NK-cell function. Interestingly,
TIGIT possesses the highest binding affinity for PVR among the
three receptors, which would imply it has a binding advantage
when the expression of PVR is limited [86]. HCMV exploits this
fact and encodes UL141, a protein that partially downregulates
PVR at the surface of infected cells, thus enabling the virus to
evade DNAM1 and CD96-mediated killing [87]. Given its high
affinity toward PVR, TIGIT can still bind PVR despite being par-
tially downregulated by HCMV, thus assuring inhibitory signaling
through this receptor. Thus, one could assume that MCMV also
employs a similar mechanism to avoid NK-cell activation by PVR-
specific activating receptors.
In contrast to other inhibitory NK-cell receptors, which mostly
recognize MHC-I molecules as their ligands, NKRP1 uses Clr-b,
a C-type lectin-like molecule as the ligand of choice to exert
its inhibitory function [88]. A recent study by Williams et al.
[36] investigated the impact of vaccinia virus (VV) and ECTV
on the expression of Clr-b on infected bone marrow-derived
macrophages. The authors found that Clr-b protein was success-
fully downregulated at the surface of infected cells, rendering
poxvirus-infected cells sensitive to NK-cell-mediated lysis [36].
Rat CMV also downregulates the cellular ligand for the NKRP1
receptor, but at the same time prevents missing self-dependent
NK-cell activation by encoding a viral homolog of Clr-b [89].
Immune regulatory role of NK cells during
viral infection
A number of groups have been trying to elucidate the key pathways
behind NK-cell-mediated immune regulation of T-cell responses
(Fig. 2). Several factors including differential kinetics and the
extent of viral replication, as well as different receptor–ligand
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Figure 2. NK-cell-mediated regulation of CD8+ T-cell responses to MCMV and LCMV infection. In addition to their already appreciated role
in controlling virus replication, NK cells possess an immune regulatory potential during the formation of adaptive immunity. (A) The NK-cell
response in Klra8 mice (BALB/c mice congenic for C57BL/6 NKC including the gene encoding Ly49H receptor) accelerates the CD8+ T-cell response
as a consequence of reduced activation of plasmacytoid DCs, decreased level of IFN-I and improved survival of cDCs (left panel middle section) [27].
An enhanced CD8+ T-cell response was achieved in mice infected with MCMV expressing RAE-1γ, most likely as a consequence of costimulation
of CD8+ T cells by ligation of their NKG2D receptor and RAE-1γ on infected DCs (left panel bottom section) [71]. The results obtained in these
two studies [27, 71], showing that improved NK-cell control positively correlates with an antiviral CD8+ T-cell response, are in contrast with the
results of two other studies [22,23] using NK-cell-sensitive and NK-cell-resistant virus strains (left and right panels, upper section). Namely, in WT
C57BL/6mice and in BALB. B6-CT8mice expressing Ly49H, Ly49H engagement with the viral proteinm157 after infection withWTMCMV results in
NK-cell-dependent virus control but impaired Ag presentation and reduced CD8+ T-cell response (right panel, upper section) [22,23]. In contrast,
infection with MCMV lacking m157 (m157) results in a much higher virus load and elevated levels of proinflammatory cytokines accompanied
by an improved CD8+ T-cell response (left panel, upper section) [22, 23]. In MCMV-infected mice lacking perforin the CD8+ T-cell response could
be further suppressed by IL-10 derived from Ly49H+ NK cells (right panel middle section) [24]. (B) In response to LCMV, activated NK cells regulate
the CD8+ T-cell response either by elimination of CD4+ T cells [21] or by NKG2D-dependent limitation of the CD8+ T-cell response [94].
pairs, may play a role in NK-cell regulation of specific immune
responses determining the outcome of viral infection [90].
Robbins et al. [27] have shown that a strong NK-cell response
to MCMV in Klra8 mice (mice on a BALB/c background con-
genic for the C57BL/6 NKC and thus positive for Ly49H) com-
pared with that of control BALB/c mice, severely decreased
the activation of plasmacytoid DCs (pDCs) and their produc-
tion of IFN-α/β, aiding the survival of conventional DCs (cDCs)
and eventually resulting in enhanced initiation of an antivi-
ral CD8+ T-cell response (Fig. 2A). In addition, the authors
have shown that exogenous IFN-α administration in MCMV-
resistant mice ablates cDCs and delays CD8+ T-cell activation
despite NK-cell control of viral replication [27]. In a differ-
ent model, infection of BALB/c and C57BL/6 mice with MCMV
engineered to express RAE-1γ also elicited a strong and long-
lasting CD8+ T-cell response despite efficient NK-cell-mediated
virus control [71]. As the NKG2D receptor is also expressed
on CD8+ T cells, costimulation of CD8+ T cells by ligation of
RAE-1γ on infected DCs could explain the enhanced priming
of CD8+ T cells regardless of the restricted viral replication.
Importantly, RAE-1γ MCMV infection preserves the frequency of
cDCs and provides protection against a lethal MCMV challenge.
Stadnisky et al. [25] have demonstrated the significance of the
inhibitory NK-cell receptor Ly49G2 in the CD8+ T-cell response
to MCMV. Namely, they showed that licensed Ly49G2+ NK cells
support recovery of splenic cDCs and thus improve the CD8+
T-cell response. NK cells were also shown to play a critical role in
the initiation and shaping of the T-cell response after influenza A
infection by supporting the recruitment of CD8+ T cells and DCs to
the posterior mediastinal lymph nodes, necessary for their priming
[91]. In addition, it has been shown that NK cells influence the
uptake and transport of influenza A virus by DCs in an IFN-γ and
perforin-dependent manner.
In contrast to the results of Stadnisky et al. [25], Andrews
et al. [23] reported that a strong NK-cell response results in a
limited virus-specific CD4+ and CD8+ T-cell response upon MCMV
infection. In addition, Lee et al. [24] suggested that IL-10 produced
by Ly49H+ NK cells in perforin-deficient mice is responsible for a
reduced CD8+ T-cell response. A more recent report reveals IL-10
involvement in CD4+ T-cell priming as well, since it was shown
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that, in the absence of IL-10, NK-DC crosstalk resulted in efficient
priming of MCMV-specific CD4+ T cells [92]. The proinflamma-
tory cytokines IL-12, IFN-γ, and TNF-α, as well as the NK-cell
activating receptors NKG2D and NCR-1, were shown to regulate
this reciprocal NK/DC interplay [92]. Finally, a study performed
using C57BL/6 mice showed that the CD8+ T-cell response in
early MCMV control inversely correlates with Ly49H-mediated
virus control [22]. Mice infected with m157 showed elevated
levels of type I IFN and several other proinflammatory cytokines
as early as 1.5 days after infection, but at the same time early cDC
function was preserved.
The immune regulatory role of NK cells can be particularly
intriguing during infection with viruses that are otherwise resis-
tant to NK-cell control. In the LCMV model, Waggoner et al. [21]
showed that activated NK cells cytolytically eliminate helper CD4+
T cells that eventually affects CD8+ T-cell function [21]. Their
finding of direct NK-cell-mediated lysis of CD4+ T cells during
LCMV infection introduces a novel mechanism by which NK cells
can regulate T-cell functions, a mechanism that is in addition to
contribution to the control of MCMV by lysis of virus-infected
APCs, a process that in turn indirectly affects the activity of virus-
specific T cells [93] (Fig. 2B). Moreover, a study by Lang et al. [94]
showed that a limited T-cell response is a consequence of NKG2D
and perforin-dependent regulatory NK-cell functions [94].
The big questions are not limited to how NK cells influence
adaptive immunity, but also what are the conditions under which
they do so, since NK cells can adjust to almost any given situation
showing their great plasticity when responding to viral infection.
Taking into account all the data published so far and the fact that
different results are obtained by using different mouse or virus
infection models, it appears that the impact of NK cells on the for-
mation of an adaptive immune response greatly depends on the
context of infection and the ability to activate NK cells through
the engagement of certain activating receptors. This strongly
suggests that there is no unique pathway in NK-cell regulation
of the adaptive immune response.
Memory NK cells in viral infections
Even though NK cells were initially classified as exclusively part
of the innate immune system, primarily due to their germline-
encoded receptors and what was initially believed to be a short
lifespan, recent studies have discovered some new adaptive-like
NK-cell features such as the recognition of specific Ags, clonal
expansion, and the formation of long-lived memory cells [95–97].
The clonal-like expansion upon recognition of specific viral Ags,
a feature until now attributed only to the cells of adaptive immu-
nity, has been reported during MCMV infection of C57BL/6 mice,
in which the Ly49H+ subset of NK cells plays a crucial role. The
adoptive transfer of Ly49H+ NK cells into DAP12–deficient hosts
proved that Ly49H+ NK-cell populations are fully capable of ensur-
ing protective immunity against secondary infection following a
ligand-specific expansion, which further confirms their memory-
like features [96]. In addition, a recent study designated IL-12 as
being important not only for achieving full NK-cell maturation and
optimal expansion of virus-specific NK cells during infection, but
also for the generation of a long-lived memory NK-cell population
[98]. By the same token, can we expect that the ligation of other
MCMV-specific Ly49 activating receptors will lead to a similar sort
of virus-specific NK-cell memory? Although there is still no other
evidence for MCMV-specific NK-cell memory, except the one via
Ly49H receptor engagement, it is important to emphasize that
even months after primary infection the majority of peripheral
NK cells, including both Ly49H+ and Ly49H− NK cells, display a
higher proliferative capacity compared with that of NK cells in
control (uninfected) mice; thus, primary antiviral immune
responses induce long-term alterations in NK cells [99]. This
is in line with a more recent study showing a higher expres-
sion of CD25, the high-affinity IL-2 receptor, on NK cells upon
MCMV infection [100]. This finding suggests that innate cytokines
released during early MCMV infection promote NK-cell prolifer-
ation even at low dose of IL-2. Further studies are required to
determine whether this early induction of high affinity IL-2 recep-
tor expression impacts subsequent memory NK-cell formation and
NK-cell regulation of specific immune responses in general.
A study conducted after the Hantavirus outbreak in
northern Sweden [101] demonstrated that human NKG2C+ NK
cells rapidly proliferate following Hanta-virus infection, and the
kinetics and extent of this response can be compared with the
clonal-like expansion of mouse Ly49H+ NK cells during MCMV
infection. Interestingly, this proliferation of NKG2C+ NK cells in
Hantavirus-infected individuals occurred in HCMV-seropositive,
but not in HCMV-seronegative patients, suggesting that these
NKG2C+ NK cells may have been primed by prior recognition of
HCMV [101]. Does this mean that NK cells can be primed by one
pathogen and be able to have a secondary response upon exposure
to a different pathogen?
It is important to mention that mouse NK-cell memory is not
restricted to only MCMV. Namely, in the study conducted by Paust
et al. [102] the results obtained by adoptive transfer of sensitized
NK cells in mouse strains lacking T and B cells indicate that a
discrete subset of liver CXCR6+ NK cells acquired and retained
Ag-specific memory to several distinct viral Ags. It is important
to emphasize that the authors managed to show this Ag-specific
response using a protocol that showed that adoptively trans-
ferred virus-sensitized NK cells enhanced the survival of recipi-
ent mice challenged with the sensitizing, but not with unrelated,
virus. Another study, performed in the absence of adaptive T and
B lymphocyte populations following VV infection, revealed liver
Thy1+ NK cells as a newly-identified NK-cell subset important for
memory-like immune protection against lethal-challenge infection
upon adoptive transfer of these Thy1+ NK cells into VV-susceptible
mice [103].
Although the discovery of NK-cell memory certainly represents
a breakthrough in the field, closing the gap between innate and
adaptive immunity, several questions still remained unanswered.
For instance, it is still not clear if and how the specific T- and
B-cell responses influence the generation of memory NK cells.
In addition, we still need to identify the molecular mechanisms
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behind the conversion of activated NK cells to memory cells, as
well as the reason why only liver-derived NK cells can achieve a
memory function.
Concluding remarks
The NK-cell response is one of the first lines of defense in fighting
viral infections. Although NK cells have primarily been described
as highly efficient effector cells that enable the early control of
viral infection, they are now being shown to be an important
link between innate and adaptive immunity, having an important
immune regulatory role in both the formation of adaptive immu-
nity and the overall outcome of infection; however, a large and
increasing body of studies published in recent years in the NK-cell
field leaves us with more questions than answers. NK-cell mem-
ory, the cross-talk of NK cells with other immune cells, NK-cell
contribution to adaptive immunity, the constant addition of new
members to the NK-cell receptor repertoire, together with as-yet
unrevealed roles for the already discovered activation receptors
are just some of the important issues that still need to be explored.
It is likely that new approaches in our understanding of NK-cell
biology in the context of viral infections will be based on genome-
wide analysis of viral and NK-cell gene expression [104], as well
as the use of information gained by other “omics” technologies.
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